How to Buy Recursion Pharmaceuticals Stock
Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery.
Recursion Pharmaceuticals stock last closed at $8.84, up 0.57% from the previous day, and has increased 71.32% in one year. It has overperformed other stocks in the Biotechnology industry by 0.9 percentage points. Recursion Pharmaceuticals stock is currently +79.67% from its 52-week low of $4.92, and -47.21% from its 52-week high of $16.75.
As of May 3, 2024, there are 234.65M shares of RXRX outstanding. The market cap of RXRX is $2.07B. In the past 24 hours, 3.93M RXRX shares were traded.
How to Buy Recursion Pharmaceuticals Stock
Wondering how to invest in Recursion Pharmaceuticals stock? Here's how.
- Figure out where to buy Recursion Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Recursion Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your method of payment and add your details.
- Evaluate Recursion Pharmaceuticals stock: The Recursion Pharmaceuticals ticker symbol is RXRX. Is Recursion Pharmaceuticals stock a good investment? Should you buy shares of RXRX? How do RXRX's underlying business fundamentals look? Do top analysts think Recursion Pharmaceuticals is a good buy? Why has RXRX's stock price moved recently? (Hint: Our stock research website can help you figure out if RXRX is a good stock to buy).
- Execute your RXRX buy order: Decide if you will purchase RXRX shares at the current market price or use a limit order to purchase RXRX stock at a given price.
- Monitor your RXRX investment: Create a watchlist to keep tabs on your position in Recursion Pharmaceuticals stock.
Step 1: Figure out where to buy Recursion Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy RXRX stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you are able to buy RXRX today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have created your account on the best stock market app, your next step is to transfer the money for your investment:
Check out this video walkthrough for more details depositing funds into your new brokerage account.
Step 4: Evaluate Recursion Pharmaceuticals stock
Once you have figured out the best place to buy Recursion Pharmaceuticals stock, it's absolutely critical to evaluate their stock before you buy, so you can understand the risk and opportunity.
Recursion Pharmaceuticals Numbers
RXRX Fundamentals
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on RXRX's stock page.
How is RXRX stock valued?
You can use many financial metrics, analyses, models, and charts to gauge RXRX's intrinsic value.
Using relative valuations metrics:
- RXRX could be undervalued based on its P/B ratio of 4.48x, relative to Biotechnology industry P/B ratio of 6.01x
You can access more valuation research on RXRX's stock here.
How do RXRX Financials look?
Signs that RXRX is financially healthy:
- RXRX has cash burn of 299735000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the RXRX balance sheet.
- There are more short-term assets than short-term liabilities on the RXRX balance sheet.
Signs that RXRX is not financially healthy:
- RXRX has $394.80M in cash and short term investments. This is not enough to cover its annual cash burn of $299.74M.
- RXRX has a relatively high debt to equity ratio of 0.41.
- RXRX profit margin has gone down from -601% to -736% in the past year.
Do analysts think it's a good time to buy RXRX stock
Out of 3 Wall Street analysts who research RXRX, the consensus analyst rating on RXRX is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Recursion Pharmaceuticals stock forecast page.
RXRX Trading Indicators
RXRX Earnings
Last year, RXRX revenue was $44.58M. Over the past four year, RXRX's revenue has increased by 109.39% per year. This was faster than the Biotechnology industry average of 29.63%.
Dive into RXRX's earnings and revenue performance here.
What are RXRX insiders up to?
Over the last year, executives and large shareholders at RXRX have sold more shares than they have bought.
Christopher Gibson, Chief Executive Officer of RXRX, was the latest RXRX insider to sell. They sold $180,377.12 worth of RXRX stock on May 2, 2024.
Get more info about who owns RXRX shares here.
Can I rely on RXRX as an income stream?
No, Recursion Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about RXRX
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your RXRX buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.
Hit the Open button and your broker will place your order.
If you require more info about investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your RXRX investment
Now that you own some RXRX stock, you'll want to keep up with your new company.
Add RXRX to a watchlist to track the latest developments regarding your RXRX stock.
RXRX Feed
How to Buy Stock in Recursion Pharmaceuticals
To summarize, here are the 6 steps to buy stock in Recursion Pharmaceuticals:
- Figure out where to buy Recursion Pharmaceuticals stock
- Sign up for a brokerage account
- Put funds into your investment account
- Evaluate Recursion Pharmaceuticals stock
- Execute your RXRX buy order
- Monitor your RXRX investment
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your investment in Recursion Pharmaceuticals, create your watchlist below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.